Literature DB >> 3573147

The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid.

D H Persing, H E Varmus, D Ganem.   

Abstract

The preS/S coding region of hepatitis B virus encodes two polypeptides (preS1 and preS2) that are larger in size but less abundant than the major viral surface antigen (S) protein. Unlike the preS2 and S proteins, the preS1 protein is preferentially localized on circulating virus particles but is not efficiently secreted from mammalian cells in culture. To search for differences in protein processing that might relate to these properties, we determined whether any of the hepatitis B virus surface proteins are acylated with long-chain fatty acids. Transfected COS cells expressing all three proteins were incubated with 3H-palmitate or 3H-myristate, and the cell extracts were examined by immunoprecipitation. While none of these proteins was labeled with 3H-palmitate, the preS1 protein but not the preS2 or S protein incorporated 3H-myristate via a hydroxylamine-resistant amide linkage. Comparison of the N-terminal amino acid sequences of hepadnaviral preS1 proteins with those of known myristylated proteins suggests that this unusual modification may be a common feature of all hepadnaviral preS1 proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573147      PMCID: PMC254153     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

2.  Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

3.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.

Authors:  F V Chisari; P Filippi; A McLachlan; D R Milich; M Riggs; S Lee; R D Palmiter; C A Pinkert; R L Brinster
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus.

Authors:  A R Neurath; S B Kent; N Strick; K Parker
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

6.  Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum.

Authors:  E J Patzer; G R Nakamura; C C Simonsen; A D Levinson; R Brands
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.

Authors:  D Pellman; E A Garber; F R Cross; H Hanafusa
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.

Authors:  K C Cheng; G L Smith; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Two classes of fatty acid acylated proteins exist in eukaryotic cells.

Authors:  A I Magee; S A Courtneidge
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  66 in total

1.  Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.

Authors:  R Prange; A Clemen; R E Streeck
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Expression of eukaryotic genes in insect cultures.

Authors:  M J Fraser
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

Review 4.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus.

Authors:  C J Ryu; D Y Cho; P Gripon; H S Kim; C Guguen-Guillouzo; H J Hong
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Unusual topological arrangement of structural motifs in the baboon reovirus fusion-associated small transmembrane protein.

Authors:  Sandra Dawe; Jennifer A Corcoran; Eileen K Clancy; Jayme Salsman; Roy Duncan
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 7.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

8.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

9.  Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

Authors:  V Bruss; K Vieluf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.